Korea Suspends J&J Subsidiary Production Of 4 OTCs
This article was originally published in The Tan Sheet
Executive Summary
The Ministry of Food and Drug Safety orders a halt to manufacturing of five products after an investigation of GMP deviations at J&J’s Korean unit. Production of each of the products will be halted between one and five months.